Ruth Jostock

USPTO Granted Patents = 34 (Patent Applications = 34)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 22 (Patent Applications = 28)

Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 100(Granted Patents)

Location History:

Solberg, DE (2012)
Stolberg, DE (2007 - 2020)

Company Filing History:

Years Active: 2007-2020

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10829480 - 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-l,3-diaza-spiro-[4.5]-decane derivatives (2020-11-10),

2. 10807989 - 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives (2020-10-20),

3. 10807988 - 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives (2020-10-20),

4. 10793556 - 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives (2020-10-06),

5. 10793528 - 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives (2020-10-06),

6. 10738015 - 1,3-diaza-spiro-[3.4]-octane derivatives (2020-08-11),

7. 8772307 - Substituted spiro compounds and their use for producing pain-relief medicaments (2014-07-08),

8. 8680159 - Bradykinin 1 receptor modulating compounds (2014-03-25),

9. 8580965 - Substituted sulfonamide compounds (2013-11-12),

10. 8541573 - Substituted sulfonamide compounds (2013-09-24),

11. 8492559 - Substituted indole compounds (2013-07-23),

12. 8455475 - Substituted spiro-amide compounds (2013-06-04),

13. 8435978 - Substituted sulfonamide compounds (2013-05-07),

14. 8357717 - Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity (2013-01-22),

15. 8318769 - Substituted sulfonamide compounds (2012-11-27),

Title: Ruth Jostock: A Trailblazer in Pharmaceutical Innovation

Introduction:

Ruth Jostock, a visionary inventor based in Stolberg, DE, has made significant contributions to the field of medicine through her relentless pursuit of excellence. With 34 patents to her name, Jostock's passion for innovation continues to inspire a new generation of inventors worldwide.

Latest Patents:

Among Jostock's latest patents are the groundbreaking inventions of 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives and 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives. These compounds hold promise in the field of medicine, particularly in the treatment of pain, showcasing Jostock's commitment to advancing healthcare through innovative solutions.

Career Highlights:

Throughout her illustrious career, Ruth Jostock has worked with renowned companies such as Grunenthal GmbH. Her innovative spirit and dedication to scientific advancement have led to the successful commercialization of several groundbreaking inventions, solidifying her status as a trailblazer in the pharmaceutical industry.

Collaborations:

Jostock's collaborative efforts with esteemed colleagues like Melanie Reich and Stefan Schunk have been pivotal in driving forward research and development initiatives. Together, they have fostered a culture of creativity and excellence, resulting in the successful implementation of cutting-edge technologies in pharmaceutical applications.

Conclusion:

Ruth Jostock's remarkable journey as an inventor exemplifies the transformative power of innovation in shaping the future of healthcare. Her unwavering commitment to excellence and groundbreaking inventions serve as a testament to her enduring legacy as a pioneer in the field of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.